ArticleImmunity, inflammation and disease2023

Clinical efficacy, safety, and subjective experience based on ePRO in HIV-infected individuals administered Bictegravir/Emtricitabine/Tenofovir Alafenamide in southwest China.

Linghong Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.